Early inflammatory cytokine response: A direct comparison between spontaneous coronary plaque destabilization vs angioplasty induced

Atherosclerosis

Volumn 236, Issue 2, 2014, Pages 456-460

  Brunetti, Natale Daniele ^a   Correale, Michele ^a   Pellegrino, Pier Luigi ^a   Munno, Irene ^b   Cuculo, Andrea ^a   De Gennaro, Luisa ^a   Gaglione, Antonio ^a   Di Biase, Matteo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Acute coronary syndrome; Atherosclerosis; Coronary angioplasty; Coronary plaque; Cytokine; Inflammation; Interleukin; Myocardial infarction

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; TROPONIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; INTERLEUKIN DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; ARTERY RUPTURE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE RESPONSE; FEMALE; HEART MUSCLE INJURY; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE EVALUATION; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; ADVERSE EFFECTS; AGED; ANGIOPLASTY; BLOOD; COMPARATIVE STUDY; MECHANICAL STRESS; MIDDLE AGED; MYOCARDIAL INFARCTION; RUPTURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY; BIOMARKERS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; RUPTURE; RUPTURE, SPONTANEOUS; STRESS, MECHANICAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; TROPONIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907085215     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.07.037     Document Type: Article

References (25)

1. Brunetti N.D., Troccoli R., Correale M., Pellegrino P.L., Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol 2006, 109:248-256.
2. Van Der Meer I.M., De Maat M.P., Hak A.E., Kiliaan A.J., Del Sol A.I., Van Der Kuip D.A., et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam study. Stroke 2002, 33:2750-2755.
3. Brunetti N.D., Pellegrino P.L., Correale M., De Gennaro L., Cuculo A., Di Biase M. Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction. J Thromb Thrombolysis 2008, 26:196-202.
4. Brunetti N.D., Munno I., Pellegrino P.L., Ruggero V., Correale M., De Gennaro L., et al. Inflammatory cytokines imbalance in the very early phase of acute coronary syndrome: correlations with angiographic findings and in-hospital events. Inflammation 2011, 34:58-66.
5. Brunetti N.D., Munno I., Pellegrino P.L., Ruggiero V., Correale M., Cuculo A., et al. Inflammatory cytokine imbalance after coronary angioplasty: links with coronary atherosclerosis. J Interv Cardiol 2007, 20:248-257.
6. Elias-Smale S.E., Kardys I., Oudkerk M., Hofman A., Witteman J.C. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 2007, 195:e195-e202.
7. Schieffer B., Schieffer E., Hilfiker-Kleiner D., Hilfiker A., Kovanen P.T., Kaartinen M., et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000, 101:1372-1378.
8. Tipping P.G., Hancock W.W. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 1993, 142:1721-1728.
9. Tenger C., Sundborger A., Jawien J., Zhou X. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells. Arterioscler Thromb Vasc Biol. 2005, 25:791-796.
10. Luo Y., Jiang D., Wen D., Yang J., Li L. Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin. Heart Vessels 2004, 19:257-262.
11. Yamashita H., Shimada K., Seki E., Mokuno H., Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 2003, 91:133-136.
12. Waehre T., Halvorsen B., Damas J.K., Yndestad A., Brosstad F., Gullestad L., et al. Inflammatory imbalance between IL-10 and TNF-α in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 2002, 32:803-810.
13. Biasucci L.M., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996, 94:874-877.
14. Arroyo-Espliguero R., Avanzas P., Cosi´n-Sales J., Aldama G., Pizzi C., Kaski J.C. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004, 25:401-408.
15. Aggarwal A., Schneider D.J., Terrien E.F., Sobel B.E., Dauerman H.L. Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. Am J Cardiol 2004, 93:6-9.
16. Ko Y.G., Jung J.H., Park S., Choi E., Joung B., Hwang K.C., et al. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction. Int J Cardiol 2006, 112:66-71.
17. Saleh N., Svane B., Jensen J., Hansson L.O., Nordin M., Tornvall P. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein andinterleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J 2005, 149:876-882.
18. Almagor M., Keren A., Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J 2003, 145:248-253.
19. Sardella G., Mariani P., D'Alessandro M., De Luca L., Pierro M., Mancone M., et al. Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thromb Res. 2006, 117:659-664.
20. Brunetti N.D., Correale M., Pellegrino P.L., Cuculo A., Biase M.D. Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings. Eur J Intern Med 2007, 18:109-117.
21. Gabriel A.S., Martinsson A., Wretlind B., Ahnve S. IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. Eur J Intern Med 2004, 15:523-528.
22. Ørn S., Manhenke C., Ueland T., Dama˚s J.K., Mollnes T.E., Edvardsen T., et al. C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Eur Heart J 2009, 30:1180-1186.
23. Hartford M., Wiklund O., Mattsson Hulte´n L., Perers E., Person A., Herlitz J., et al. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up. Int J Cardiol 2006, 108:55-62.
24. Pudil R., Pidrman V., Krejsek J., Gregor J., Tichy´ M., Andry´s C., et al. Cytokines and adhesion molecules in the course of acute myocardial infarction. Clin Chim Acta 1999, 280:127-134.
25. Kehmeier E.S., Lepper W., Kropp M., Heiss C., Hendgen-Cotta U., Balzer J., et al. TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention. Clin Res Cardiol 2012, 101:815-827.